Point mutations in the SCN4A gene are responsible for skeletal muscle sodium channel diseases, expanding the recognized phenotypes to include sodium channel myotonia.
No takes yet. Share an insight, caveat, or question.
May support SCN4A testing in select myotonic disorders; leaves open targeted therapy development.
Bergh et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: